Target intelligence / Profile preview

Endogenous adult stem cell mobilization

Molecular classification
Other
01

Overview

Endogenous adult stem cell mobilization" refers to the activation and recruitment of adult stem cells, particularly from the bone marrow and, to a lesser extent, adipose tissue and other organs, into the peripheral blood for the purpose of tissue repair and regeneration. This process is commonly stimulated pharmacologically using agents such as granulocyte colony-stimulating factor (G-CSF) and plerixafor (AMD3100), which disrupt retention signals or otherwise activate stem cell proliferation and release. Mobilized stem cells can then travel to sites of injury or degeneration to contribute to tissue healing. This approach is being explored for a wide range of degenerative diseases and as an adjunct to regenerative medicine and cell therapy, but it does not denote a single molecular entity—rather, it is a therapeutic strategy leveraging multiple molecular and cellular pathways[1][2][3].

Other names
Endogenous stem cell mobilizationAdult stem cell mobilizationESCM
02

Mechanism of action

Stimulation of stem cell egress from bone marrow or other niches to peripheral blood by disrupting retention signals or enhancing chemotaxis (e.g., inhibition of CXCR4-SDF1 interaction by AMD3100; stimulation of progenitor cell proliferation by G-CSF)

03

Biological functions

Tissue repair and regenerationCell proliferationImmune responseWound healing
04

Disease associations

Degenerative diseaseCardiovascular diseaseDiabetesNeurodegenerative diseaseCancer (therapeutic, not causative)
05

Safety considerations

Risk of mobilizing malignant or pre-malignant cellsPossible exacerbation of inflammatory or autoimmune conditionsCytokine release or systemic inflammation (noted with some mobilizing agents)Off-target tissue effects
06

Interacting drugs

Granulocyte colony-stimulating factor (G-CSF)

2 more in the full profile.

07

Biomarkers

CD34+ cell count in peripheral blood (marker for mobilized hematopoietic stem/progenitor cells)Circulating MSC (mesenchymal stromal cell) countsOther cell surface markers depending on stem cell type

Beyond the preview

Go deeper on Endogenous adult stem cell mobilization.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous adult stem cell mobilization.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call